Abstract
Metabolomics as a progressive tool for pharmaco-toxicological research is gradually proving its value in toxicity according to the strategy for making a chronological assessment of new and developing diseases. The aim of the new approaches is to use the most complete statistics to summarize information protocols using food safety protocol approaches, and to reduce the number of cases in biomodeling studies and time. The term "metabolomics" refers to the measurement of small molecules, which are the particular probability of biological systems (cells, tissues, organisms, etc.) at a particular point in time. The main purpose of the review is to give an idea of planning and a number of metabolic studies to use an arsenal of methodological approaches, incl. in arbitration toxicology.The collection and analysis of scientific publications was carried out according to the recommendation of H. Snyder for writing review articles. In Russian, they are presented in various bibliographic databases (Elibrary, Pubmed, Scopus (Elsevier), Web of Science (Clarivate)) later publications.The need for a toxicological assessment of new cases identified highlights metabolomics as the most promising method for testing the safety of pharmaceutical substances. Metabolomic studies have a high potential to detect biomarkers that indicate the toxicity of natural compounds.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have